Cortisol as a marker for improvement in mindfulness-based stress reduction

Area of Science:

• Psychoneuroendocrinology
• Behavioral Medicine
• Mindfulness Research

Background:

• Mindfulness-Based Stress Reduction (MBSR) programs are studied for chronic condition management.
• Current research predominantly uses self-report measures, which may lack objectivity.
• There is a need for physiological markers to validate MBSR efficacy.

Purpose of the Study:

• To review the literature on cortisol as a physiological marker for MBSR.
• To assess cortisol's role in validating self-reported improvements from mindfulness practice.
• To provide recommendations for future research designs.

Main Methods:

• Literature review of studies investigating MBSR and cortisol levels.
• Analysis of cortisol's utility as a biomarker for stress reduction.
• Synthesis of findings to evaluate objective versus subjective outcome measures.

Main Results:

• Cortisol, a primary stress hormone, is a potential objective marker for MBSR effects.
• Integrating cortisol measurements can enhance the validity of MBSR outcome research.
• Self-report measures alone may not fully capture the physiological impact of MBSR.

Conclusions:

• Cortisol level measurement presents a valuable objective biomarker in MBSR research.
• Future studies should incorporate cortisol assays to complement self-report data.
• This approach will strengthen the evidence base for MBSR in chronic disease management.